« back

Health Technology Assessment (HTA): Primary research: Stage 1

  Wednesday, 01 Apr 2020 | Funding Deadline

• 19/120 Relapsing polymyalgia rheumatica
• 19/121 The clinical and cost effectiveness of pulse oximetry screening for hypoxaemia in newborn babies
• 19/122 A cross-sectional study and modelled evaluation of the performance of bowel cancer screening in England
• 19/123 Oxybutynin for the treatment of vasomotor symptoms associated with menopause
• 19/124 Effectiveness of meniscal allograft transplantation
• 19/125 Cardiac rehabilitation for stable angina
• 19/126 Suspending proton pump inhibitors to reduce Clostridium difficile infection
• 19/127 Surgery for endometrioma in women undergoing IVF
• 19/128 Administration routes of steroids in the first-line treatment of idiopathic sensorineural hearing loss
• 19/129 Lumbar fusion for low back pain

The Health Technology Assessment Programme is accepting stage 1 applications to their commissioned workstream for this primary research topic.

All deadlines are 1pm (UK time) unless otherwise specified.